Last reviewed · How we verify

NCT06109987

Clinical Evaluation of Bulk-fill Restorative Materials

Completed Last updated 23 April 2024
What this trial tests

trial testing World Dental Federation criteria (FDI) in Caries; Dentin in 160 participants. Completed in 17 September 2023.

Timeline
11 October 2021
Primary endpoint
15 July 2022
17 September 2023

Quick facts

Lead sponsorRecep Tayyip Erdogan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment160
Start date11 October 2021
Primary completion15 July 2022
Estimated completion17 September 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Recep Tayyip Erdogan University

Who can join

18 and older, any sex, with Caries; Dentin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High-viscosity glass ionomer cements have been developed to improve the weak mechanical properties of glass ionomer cements, increase wear resistance and improve their limited indications. There are limited clinical studies on the use of high-viscosity glass ionomer cements in areas with large cavities bearing stress. The aim of this study is to compare the clinical performance of two different high-viscosity glass ionomer cements with a bulk-fill resin composite in different cavities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of World Dental Federation criteria (FDI)

Trials testing the same drug.

Other recruiting trials for Caries; Dentin

Currently open trials in the same condition.

Other Recep Tayyip Erdogan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06109987.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing